View Author
patient myeloma therapy study treatment bortezomib blood disease marker dexamethasone cancer trial thalidomide university lenalidomide j clin oncol survival regimen serum agent novel myeloma patients signi group novel agents phase induction response type i collagen transplantation outcome collagen cycle department risk strati fication maintenance result melphalan celgene signi ficantly hospital level oncol prednisone randomized erasmus mc combination prognostic hematology resorption ef ficacy number bone resorption effect terpo leukemia fication table induction therapy cytogenetic factor myeloma e terpos center autologou formation strati days 1-4 high-dose consensus cyclophosphamide comorbidity bone disease ficantly br j haematol ն 75 years haematol diagnosis analysis volume myeloma bone disease
5 Most Recent Publications
|
Personalized therapy in multiple myeloma according to patient age and vulnerability: A report of the European Myeloma Network (EMN)
(Article)
Palumbo, A. Bringhen, S. Zweegman, S. Terpos, E. Davies, F. Driessen, C. Gimsing, P. Gramatzki, M. Hajek, R. Johnsen, H.E. Da Costa, F.L. Sezer, O. Ludwig, H. Spencer, A. Beksaç, M. Morgan, G. Einsele, H. San Miguel, J. Sonneveld, P. Dimopoulos, M.A. Bladé, J. Mateos, M.V. Rosiñol, L. Boccadoro, M. Cavo, M. Lokhorst, H.M. |
2011-10-27
|
|
International myeloma working group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
(Article)
Cavo, M. Rajkumar, S.V. Sonneveld, P. Boccadoro, M. Anderson, K.C. Richardson, P.G. Bensinger, W. Johnsen, H.E. Kroeger, N. Gahrton, G. Bergsagel, P.L. Vesole, D.H. Palumbo, A. Einsele, H. Jagannath, S. Niesvizky, R. Durie, B.G.M. Miguel, J.S. Lonial, S. Moreau, P. Orlowski, R.Z. Bladé, J. Sezer, O. Ludwig, H. Dimopoulos, M.A. Attal, M. |
2011-06-09
|
|
Consensus recommendations for risk stratification in multiple myeloma: Report of the International Myeloma Workshop Consensus Panel 2
(Article)
Munshi, N.C. Anderson, K.C. Jagannath, S. Hajek, R. Sezer, O. Kyle, R. Sonneveld, P. Cavo, M. Rajkumar, S.V. San-Miguel, J-F. Crowley, J. Avet-Loiseau, H. Bergsagel, P.L. Shaughnessy, J. Palumbo, A. Durie, B.G.M. Fonseca, R. Stewart, A.K. Harousseau, J-L. Dimopoulos, M.A. |
2011-05-05
|
|
European Myeloma Network: The 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma
(Article)
Engelhardt, M. Udi, J. Driessen, C. Patriarca, F. Gramatzki, M. Terpos, E. Sezer, O. Kropff, M. Straka, C. Johnsen, H.E. Waage, A. Boegsted, M. Kleber, M. Lokhorst, H.M. Hjek, R. Morgan, G. Boccadoro, M. Ludwig, H. Cavo, M. Polliack, A. Sonneveld, P. Einsele, H. Palumbo, A. Spencer, A. Rocci, A. Knop, S. Bruno, B. Bringhen, S. Pérez-Simn, J.A. Zweegman, S. |
2010-11-01
|
|
The use of biochemical markers of bone remodeling in multiple myeloma: A report of the International Myeloma Working Group
(Article)
Terpos, E. Dimopoulos, M.A. Palumbo, A. Sonneveld, P. Drake, M.T. Harousseau, J-L. Anderson, K.C. Durie, B.G.M. Sezer, O. Roodman, D. Abildgaard, N. Vescio, R. Tosi, P. Garcia-Sanz, R. Davies, F. Chanan-Khan, A. |
2010-10-01
|
